- Home
- SNPX vs WATT Comparison
SNPX vs WATT Comparison
Compare SNPX & WATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNPX
- WATT
- Stock Information
- Founded
- SNPX 2012
- WATT 2012
- Country
- SNPX United States
- WATT United States
- Employees
- SNPX N/A
- WATT N/A
- Industry
- SNPX Medicinal Chemicals and Botanical Products
- WATT Radio And Television Broadcasting And Communications Equipment
- Sector
- SNPX Health Care
- WATT Technology
- Exchange
- SNPX Nasdaq
- WATT Nasdaq
- Market Cap
- SNPX 4.1M
- WATT 3.9M
- IPO Year
- SNPX N/A
- WATT 2014
- Fundamental
- Price
- SNPX $2.40
- WATT $0.52
- Analyst Decision
- SNPX Strong Buy
- WATT Strong Buy
- Analyst Count
- SNPX 1
- WATT 2
- Target Price
- SNPX $14.00
- WATT $2.25
- AVG Volume (30 Days)
- SNPX 18.6K
- WATT 207.2K
- Earning Date
- SNPX 11-12-2024
- WATT 11-12-2024
- Dividend Yield
- SNPX N/A
- WATT N/A
- EPS Growth
- SNPX N/A
- WATT N/A
- EPS
- SNPX N/A
- WATT N/A
- Revenue
- SNPX N/A
- WATT $431,184.00
- Revenue This Year
- SNPX N/A
- WATT $95.75
- Revenue Next Year
- SNPX N/A
- WATT $834.07
- P/E Ratio
- SNPX N/A
- WATT N/A
- Revenue Growth
- SNPX N/A
- WATT N/A
- 52 Week Low
- SNPX $2.32
- WATT $0.50
- 52 Week High
- SNPX $8.78
- WATT $2.75
- Technical
- Relative Strength Index (RSI)
- SNPX 33.10
- WATT 36.29
- Support Level
- SNPX $2.88
- WATT $0.50
- Resistance Level
- SNPX $3.20
- WATT $0.58
- Average True Range (ATR)
- SNPX 0.19
- WATT 0.04
- MACD
- SNPX -0.06
- WATT -0.00
- Stochastic Oscillator
- SNPX 8.88
- WATT 15.13
About SNPX Synaptogenix Inc.
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.
About WATT Energous Corporation
Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. Its products include Transmitter IC & Module, Receivers IC, Transmitter System and other tools.